Overview Sodium Tungstate in Obesity Status: Completed Trial end date: 2009-05-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the efficacy and safety of sodium tungstate versus placebo in patients with obesity (grade I and II). Phase: Phase 2 Details Lead Sponsor: Hospital Clinic of BarcelonaCollaborators: Fundacio ClinicFundacio Clinic Barcelona